3542 results for «2145»
3542 results
Major Late-Breaking Trials from EuroPCR 2025
21 May 2025 – From EuroPCR 2025
Discover major late-breaking trials from EuroPCR 2025 in this session presenting pivotal study data. Highlights include meta-analyses from the PROTECTED TAVR and BHF PROTECT-TAVI studies, angiography versus physiology-guided PCI during TAVI (FAITAVI trial), and novel antiplatelet strategies following drug-coated stent implantation in acute coronary syndrome, with...
Challenging STEMI cases: unwanted situations
21 May 2025 – From EuroPCR 2025
Address challenging STEMI cases involving multivessel disease, high thrombus burden, and spontaneous coronary artery dissection. This session provides case-based learning on managing unexpected scenarios, diagnostic approaches, and tailored treatment strategies in complex STEMI presentations.
TAVI for bioprosthetic valve failure - LIVE Case
22 May 2025 – From EuroPCR 2025
A 68-year-old male patient with a history of Sapien 3 26 mm TAVI (2021), complicated by the need for two valves (one displaced in the descending aorta) and permanent pacemaker implantation, as well as endocarditis (2022), presented with symptomatic bioprosthesis failure and reduced LV function (20...
Two-stent techniques for non-left main true bifurcation lesions
22 May 2025 – From EuroPCR 2025
Enhance your skills in two-stent techniques for non-left main true bifurcation lesions. This session covers patient and lesion assessment, PCI procedural steps, and common pitfalls to avoid, aiming to improve procedural success in complex coronary anatomies.
Tricuspid hotline: new devices
22 May 2025 – From EuroPCR 2025
Discover cutting-edge developments in transcatheter tricuspid valve replacement with new device technologies. Review first-in-human trials, early outcomes from multicenter studies, and innovative designs that promise to advance tricuspid regurgitation treatment.
Improving outcomes of NSTEMI patients
21 May 2025 – From EuroPCR 2025
Review contemporary evidence on improving outcomes for NSTEMI patients. Topics include the effects of evolocumab on stent coverage, impact of left ventricular function with kidney disease, GRACE score-based outcomes, PCI timing, and early initiation of Tafolecimab.
Wireless physiology assessment
22 May 2025 – From EuroPCR 2025
This session examines the evolving field of wireless physiology assessment in PCI. Topics include randomized trials comparing angiography and physiology guidance, prognostic performance of imaging-derived physiology, and outcomes in various patient subsets including elderly patients with multivessel disease.
Mitral TEER in challenging scenarios - Part 3
21 May 2025 – From EuroPCR 2025
This session focuses on challenging mitral TEER cases, including papillary muscle rupture post-myocardial infarction, advanced heart failure treatment, emerging therapies for mitral regurgitation, and novel percutaneous repair techniques.
Hotline TAVI 3: Challenging anatomical and clinical scenarios
22 May 2025 – From EuroPCR 2025
This hotline session presents challenging anatomical and clinical scenarios in TAVI, including outcomes in bicuspid aortic valve patients, chronic aortic regurgigation, comparisons of surgical versus percutaneous approaches, and real-world data on valve performance and resource utilization.
Inludes:
- Five-year outcomes from the Evolut low risk TAVR bicuspid study
- Surgical versus...
Hypertension interventions in specific scenarios
22 May 2025 – From EuroPCR 2025
Explore interventions for hypertension in specific patient populations, including renal artery stenosis treatment and the role of renal denervation. Discuss multidisciplinary approaches and evidence supporting renal denervation in advanced kidney disease, heart failure, and young patients.
STEMI in special circumstances
22 May 2025 – From EuroPCR 2025
Address STEMI management in special circumstances such as spontaneous coronary artery dissection, ectatic vessels, and high thrombotic burden. Learn when surgical referral is appropriate and explore interventional strategies tailored to complex STEMI presentations.
Pulmonary embolism - What should we do in the cathlab?
22 May 2025 – From EuroPCR 2025
Explore this session focused on pulmonary embolism management in the cathlab, highlighting when pharmacotherapy is insufficient and reviewing interventional options anticipated in 2025. Engage with real cases including polytrauma with acute respiratory failure and complex presentations like pre-syncope and scoliosis, accompanied by expert discussions and key...
From probe to patient: understanding echocardiography in structural heart disease
22 May 2025 – From EuroPCR 2025
Build foundational knowledge of echocardiography in structural heart disease. This session covers basic principles, diagnostic approaches correlating symptoms with valvular disease, and the vital role of echocardiography in post-procedural assessment and follow-up.
TAVI - Head-to-head comparative studies
22 May 2025 – From EuroPCR 2025
Compare head-to-head outcomes of various TAVI devices through real-world registries and meta-analyses. This session provides insights into performance differences between self-expanding and balloon-expandable valves to inform clinical decision-making.
Optimal use of cardiac imaging to plan and guide transcatheter LAA closure
22 May 2025 – From EuroPCR 2025
Optimize left atrial appendage (LAA) closure outcomes through expert use of cardiac imaging. This session details the role of various imaging modalities in pre-procedural planning, intraprocedural guidance, and post-procedural assessment. Gain practical insights on transesophageal echocardiography, computed tomography, intracardiac echocardiography, and their integration to enhance procedural...
Assessment and management of patients with multivalvular disease involving the tricuspid valve
22 May 2025 – From EuroPCR 2025
Gain expertise on managing multivalvular disease involving the tricuspid valve by understanding diagnostic challenges, intervention indications, and associated pathophysiological factors. This session includes complex case studies focusing on combined valvular lesions and guideline limitations.
Pharmacotherapy coronary interventions: new insights
22 May 2025 – From EuroPCR 2025
Stay abreast of new insights in pharmacotherapy for coronary interventions with a focus on optimizing patient outcomes. Topics include ticagrelor monotherapy in chronic coronary syndrome post-PCI, analysis of multiple events in high bleeding risk patients from the MASTER DAPT trial, effects of beta-blocker interruption in MI...
Role of coronary physiology in acute coronary syndrome patients
22 May 2025 – From EuroPCR 2025
Examine the role of coronary physiology in acute coronary syndrome patients, including plaque characteristics related to ACS risk, prognostic value of AngioIMR in STEMI, functional significance of lumen and plaque features, diagnostic accuracy of quantitative flow ratio, and the impact of adenosine administration routes on FFR...
All you need to know on aorto iliac disease during TAVI: from access to complications management
22 May 2025 – From EuroPCR 2025
Gain expertise in managing aorto-iliac disease during TAVI procedures, from access planning to complication management. This session covers key imaging techniques, decision-making regarding stenting and lesion modification, approaches to access-related complications, and criteria for involving vascular surgeons, ensuring procedural safety and success.
What an interventional cardiologist should know about anti-thrombotics
22 May 2025 – From EuroPCR 2025
This session provides comprehensive knowledge on anti-thrombotic management for interventional cardiologists, emphasizing effective inhibition during acute STEMI, latest evidence implementation for high bleeding risk patients, and customization of dual antiplatelet therapy in patients with high thrombotic and low bleeding risks through clinical cases and evidence-based recommendations.
